ofloxacin has been researched along with brl 28500 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baetz, R; Borner, K; Lebahn, K; Lode, H; Olschewski, P; Reinke, M; Sievers, H; Wagner, J; Wiley, E; Wintermantel, M | 1 |
Corrado, M; Fowler, CL; Graham, DR; Lucasti, C; Morgan, N; Nichols, RL; Talan, DA | 1 |
2 trial(s) available for ofloxacin and brl 28500
Article | Year |
---|---|
Prospective randomized clinical trials of new quinolones versus beta-lactam antibiotics in lower respiratory tract infections.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Clavulanic Acids; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Ofloxacin; Pneumonia; Prospective Studies; Remission Induction; Respiratory Tract Infections; Sepsis; Ticarcillin | 1990 |
Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: a randomized, open-label trial.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Skin Diseases; Ticarcillin; Treatment Outcome | 2002 |